Devi Reddy Gohimukkula

USPTO Granted Patents = 10 (Patent Applications = 1)

CIPO Patents = 2

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 11.7

ph-index = 3

Forward Citations = 27(Granted Patents)

Company Filing History:

5 out of 49

Transtech Pharma, Inc.

patents

4 out of 50

High Point Pharmaceuticals, LLC

Years Active: 2013-2015

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9175003 - Substituted azoanthracene derivatives and intermediates for preparation thereof (2015-11-03),

2. 9045461 - Phenyl-heteroaryl derivatives and methods of use thereof (2015-06-02),

3. 8987295 - Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof (2015-03-24),

4. 8946259 - Benzazole derivatives, compositions, and methods of use as beta-secretase inhibitors (2015-02-03),

5. 8741900 - Phenyl-heteroaryl derivatives and methods of use thereof (2014-06-03),

6. 8598353 - Benzazole derivatives, compositions, and methods of use as β-secretase inhibitors (2013-12-03),

7. 8450354 - Substituted imidazo[1,2-b]pyridazine derivatives, pharmaceutical compositions, and methods of use as β-secretase inhibitors (2013-05-28),

8. 8431575 - Phenyl-heteroaryl derivatives and methods of use thereof (2013-04-30),

9. 8383644 - Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof (2013-02-26),

10. 8350039 - Substituted isoquinoline derivatives, pharmaceutical compositions, and methods of use as beta-secretase inhibitors (2013-01-08),

Title: **Inventor Spotlight: Devi Reddy Gohimukkula**

Introduction

Devi Reddy Gohimukkula is an accomplished inventor based in Jamestown, NC, showcasing a robust portfolio of 10 patents. Her innovative work primarily focuses on the development of compounds beneficial in the pharmaceutical industry, particularly in the treatment of various diseases.

Latest Patents

Among her latest patents, Gohimukkula has developed "Substituted azoanthracene derivatives and intermediates for preparation thereof." This invention pertains to substituted azoanthracene derivatives ideal for creating pharmaceutical compositions aimed at modulating the human GLP-1 receptor, which plays a critical role in various metabolic processes.

Another significant patent is for "Phenyl-heteroaryl derivatives and methods of use thereof." This invention introduces phenyl-heteroaryl derivatives that are effective in treating RAGE-mediated diseases. It encompasses methods for preparing these compounds, their pharmaceutically acceptable salts, and their applications in therapeutic compositions.

Career Highlights

Gohimukkula has contributed her expertise to notable companies such as Transtech Pharma, Inc. and High Point Pharmaceuticals, LLC, where she has played a pivotal role in advancing pharmaceutical innovations. Her commitment to research and development has made significant strides in enhancing treatment options for patients with specific medical conditions.

Collaborations

Throughout her career, Devi Reddy Gohimukkula has collaborated with leading professionals in her field, including Robert Carl Andrews and Adnan M M Mjalli. These partnerships have fostered a rich exchange of ideas and expertise, further enhancing her contributions to pharmaceutical research and innovation.

Conclusion

Devi Reddy Gohimukkula exemplifies the spirit of innovation, with her ten patents marking her significant impact in the field of pharmaceutical development. Her ongoing work continues to hold promise for future medical breakthroughs, making her an influential figure in the realm of biotechnology and inventions.

This text is generated by artificial intelligence and may not be accurate.